- Vector Safety
- Gene Editing (Off) Targets
- Immune Repertoire
- Sequence Analysis
- Gene Expression
Platform for DNA- or RNA-Fusion Sequences
GeneWerk GmbH provides highly sensitive platforms and bioinformatics to determine fusion sequences adjacent to known DNA or RNA fragments in minimal tissue samples down to the single cell level.
Applications include clonality and safety of (viral) vectors in gene therapy, on-target specificity of designer nucleases, immune repertoire studies in T cells and B cells and next generation sequencing (NGS).
GeneWerk’s unique worldwide experience in gene therapy studies, bioinformatics, NGS, and associated regulatory demands can help to build the solutions you need by individual consultation.
Jun 04 Insight into Spatial and Temporal Trends of SARS-CoV‑2 Infection Outbreak
May 12 Meet GeneWerk at the ASGCT 23rd Annual Meeting
Visit us from May 12-15, 2020 in Boston Read more … Meet GeneWerk at the ASGCT 23rd Annual Meeting